IDEAYA Announces Closing of Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares
IDEAYA Biosciences closed its underwritten public offering, generating approximately $345.0 million in gross proceeds. The offering consisted of 7.22 million shares of common stock priced at $27.00 per share and 5.56 million pre-funded warrants priced at $26.9999. Underwriters fully exercised their option to purchase an additional 1.67 million shares, signaling strong demand for the precision medicine oncology company's securities. J.P.
Key figures
- Deal Value Usd
- 345000000
- Offering Price
- 27
- Shares Offered
- 7222225
- Greenshoe shares
- 1666669
- Prefunded warrants offered
- 5555576
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.